Federica Blua

5PUBLICATIONS
32CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)NanomaterialsBiologically active moleculesChemical thermodynamics and energeticsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 16, 2026
Beneficial Effects of a Dual Cyclooxygenase Inhibitor-Thromboxane Antagonist in Counteracting High-Fat Diet-Induced Metaflammation.

|Oct 29, 2025
Solid Lipid Nanoparticles by Coacervation from Natural Soaps: Preliminary Studies for Oral Delivery of an Insulin Analogue.

Annalisa Bozza, Arianna Marengo, Federica Blua

|Oct 22, 2025
Exploiting the 2-(1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl)acetic Acid Scaffold to Generate COXTRANs: A New Class of Dual Cyclooxygenase Inhibitors-Thromboxane Receptor Antagonists.

Federica Blua, Francesca Boccato, Carola Buccellati

|Feb 25, 2023
Comparative Study of Different H2S Donors as Vasodilators and Attenuators of Superoxide-Induced Endothelial Damage.

Elisabetta Marini, Barbara Rolando, Federica Sodano

|Dec 11, 2022
Investigation into the Use of Encorafenib to Develop Potential PROTACs Directed against BRAFV600E Protein.

Elisabetta Marini, Marco Marino, Giulia Gionfriddo

Pageof 1

Frequent Collaborators

4 joint publications

Elisabetta Marini

4 joint publications

Barbara Rolando

3 joint publications

Massimo Bertinaria

2 joint publications

Marta Giorgis